Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.

ABSTRACT: Longstanding social and economic inequities elevate health risks and vulnerabilities for Black, Indigenous and People of Color (BIPOC) communities. Engagement of BIPOC communities in infectious disease research is a critical component in efforts to increase vaccine confidence, acceptability, and uptake of future approved products. Recent data highlight the relative absence of BIPOC communities in vaccine clinical trials. Intentional and effective community engagement methods are needed to improve BIPOC inclusion. We describe the methods utilized for the successful enrollment of BIPOC participants in the U.S. Government (USG)-funded COVID-19 Prevention Network (CoVPN)-sponsored vaccine efficacy trials and analyze the demographic and enrollment data across the efficacy trials to inform futur

SUBMITTER: Andrasik MP 

PROVIDER: S-EPMC8525736 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature